Mangoceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Mangoceuticals, Inc. (MGRX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Current Assets
Cash and Cash Equivalents0.060.740.680.02
Cash & Short-Term Investments0.060.740.680.02
Accounts Receivable0.000.000.000.00
Inventory0.000.020.000.00
Other Current Assets0.020.000.010.00
Total Current Assets0.080.840.690.02
Non-Current Assets
Property, Plant & Equipment (Net)0.060.220.290.00
Intangible Assets15.230.000.000.00
Other Non-Current Assets0.000.000.020.00
Total Non-Current Assets15.290.220.310.00
Total Assets15.371.051.000.02
Current Liabilities
Accounts Payable0.840.140.030.00
Short-Term Debt0.150.000.170.04
Accrued Liabilities0.000.010.000.00
Other Current Liabilities0.370.000.000.00
Total Current Liabilities1.430.210.260.04
Non-Current Liabilities
Long-Term Debt0.000.060.130.00
Other Non-Current Liabilities0.000.000.000.00
Total Non-Current Liabilities0.000.060.130.00
Total Liabilities1.430.280.390.04
Stockholders' Equity
Common Stock0.000.000.000.00
Retained Earnings-20.81-11.23-2.02-0.02
Accumulated Other Comprehensive Income-0.010.000.000.00
Additional Paid-in Capital35.5912.002.630.00
Minority Interest0.000.000.000.00
Shares Outstanding3.251.431.021.02
Total Stockholders' Equity13.950.770.61-0.02
Total Liabilities & Equity15.371.051.000.02